rs1049742 — AOC1

Missense variant in the diamine oxidase enzyme that contributes to reduced histamine clearance from dietary sources

See your personal result for AOC1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

AOC1 Ser332Phe — Histamine Clearance in the Gut

Every meal containing aged cheese, cured meat, fermented foods, or a glass of wine delivers a histamine load to your gut. For most people this goes unnoticed — the diamine oxidase (DAO) enzyme11 diamine oxidase (DAO) enzyme
DAO (diamine oxidase): the primary intestinal barrier against dietary histamine, encoded by the AOC1 gene neutralises it before it can enter circulation. But for carriers of certain AOC1 variants, that barrier is thinner. The rs1049742 variant (p.Ser332Phe, c.995C>T) is one of four clinically recognised AOC1 polymorphisms associated with reduced DAO enzyme competence in Caucasian populations.

The Mechanism

The rs1049742 variant swaps a serine residue for a phenylalanine at position 332 of the DAO protein. Serine and phenylalanine differ substantially in polarity and size, so the substitution alters the local protein fold near the active-site copper centre. DAO is a copper-containing amine oxidase that requires copper, vitamin B6 (as pyridoxal phosphate), and vitamin C as cofactors. Any structural perturbation that reduces catalytic efficiency or expression level lowers the intestinal mucosal barrier against dietary histamine, polyamines such as putrescine, and other biogenic amines.

Critically, rs1049742 has a smaller independent effect on serum DAO activity22 smaller independent effect on serum DAO activity
Ayuso et al. 2007 (PMID 17700358) found Ser332Phe showed negligible individual impact, while His645Asp (rs1049793) reduced enzyme Vmax/Km to 66% in heterozygotes and 51% in homozygotes than the two more common AOC1 variants (rs10156191 and rs1049793). Its clinical relevance appears primarily cumulative — in multiple studies, rs1049742 was only detected in individuals who also carried at least two of the other three AOC1 risk variants.

The Evidence

Ayuso et al. (2007)33 Ayuso et al. (2007)
Genetic variability of human diamine oxidase: occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity. Pharmacogenet Genomics, 2007 characterised three non-synonymous AOC1 polymorphisms in 134 Caucasian individuals. The T allele frequency of rs1049742 was 6.3%, lower than the ~25% and ~31% seen for rs10156191 and rs1049793. The His645Asp (rs1049793) variant showed a clear gene-dose effect on DAO activity (P<0.001), but the Ser332Phe effect was described as negligible in isolation.

A 2023 fibromyalgia pilot study44 A 2023 fibromyalgia pilot study
Navarrete-Moreno et al. 2023. Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia. Front Genet, 2023 examined all four AOC1 variants in 100 women and noted that fibromyalgia symptom burden (measured on the FIQ) tended to increase with total risk-allele count. Notably, rs1049742 was never observed alone or with only one or two other variants — it appeared exclusively in individuals carrying all three remaining AOC1 variants, suggesting it operates as a modifier that compounds an already-reduced DAO baseline.

A histamine intolerance prevalence study (PMC11054051, 2024)55 A histamine intolerance prevalence study (PMC11054051, 2024)
Pilot study in 100 patients with histamine intolerance symptoms vs 100 controls. Nutrients 2024 found rs1049742 in 18% of symptomatic patients vs 13% of controls (p = 0.329, not significant), and concluded it is unlikely to be clinically useful as a standalone diagnostic marker. European genotype frequencies in this dataset: CC 86.0%, CT 13.4%, TT 0.5%.

For DAO supplementation, Schnedl et al. 201966 Schnedl et al. 2019
Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. Food Sci Nutr, 2019 showed all symptoms significantly improved over 4 weeks of oral DAO (porcine kidney extract) before meals in 28 patients (Wilcoxon p<0.0001). Symptoms partially returned after stopping, suggesting ongoing enzyme support is needed.

Practical Actions

Carriers of the CT or TT genotype — especially those also carrying rs1049793 or rs10156191 — benefit most from identifying and reducing their dietary histamine load. High-histamine foods include aged cheeses (parmesan, gouda, emmental), cured and smoked meats, fermented vegetables (sauerkraut, kimchi), alcoholic drinks (especially red wine and beer), vinegar, and spinach. Histamine-releasing foods (strawberries, tomatoes, citrus, shellfish) can also trigger symptoms in sensitive individuals by prompting mast cells to release endogenous histamine.

Supplemental DAO (porcine kidney extract) taken before histamine-rich meals can partially compensate for reduced endogenous enzyme activity. Adequate cofactor intake — vitamin C, vitamin B6 as pyridoxal-5-phosphate, and copper — supports remaining enzyme function.

Interactions

AOC1 carries four clinically recognised low-DAO risk variants. rs1049742 appears to function primarily as a cumulative modifier. The strongest independent actors are rs10156191 (p.Thr16Met) and rs1049793 (p.His645Asp), which show clear gene-dose effects on DAO serum activity. rs2052129 is a promoter variant that reduces transcriptional activity. Individuals carrying two or more of these variants show substantially higher symptom burden than single-variant carriers. The HNMT gene (histamine N-methyltransferase, rs1050891) controls intracellular histamine degradation independently of AOC1 and may interact additively.

Nutrient Interactions

histamine impaired_conversion
vitamin C increased_need
vitamin B6 increased_need
copper increased_need

Genotype Interpretations

What each possible genotype means for this variant.

CC Normal DAO Activity Normal

Standard diamine oxidase activity — no increased dietary histamine sensitivity from this variant

You carry two copies of the common C allele at rs1049742, which means the AOC1 gene at this position encodes the standard serine residue at position 332 of the DAO enzyme. This variant does not contribute to reduced histamine clearance capacity. About 86% of people of European descent share this genotype.

CT Reduced DAO Activity Reduced

One copy of the Ser332Phe variant — modest contribution to reduced DAO histamine-clearing capacity

The Ser332Phe substitution alters local protein folding near the copper-binding active site of DAO. Published studies have found negligible independent impact of this variant on serum DAO activity, but rs1049742 consistently appears as a cumulative modifier in individuals who already carry two or more other low-activity AOC1 alleles. The clinical pattern is one of progressive reduction in the histamine clearance barrier with each additional risk allele.

Histamine intolerance symptoms — including headaches, nasal congestion, skin flushing, tachycardia, bloating, and diarrhoea — typically occur 30–60 minutes after consuming histamine-rich foods and resolve within hours. The key diagnostic feature is symptom improvement on a low-histamine diet, not the genetics alone.

TT Low DAO Activity Reduced

Two copies of the Ser332Phe variant — cumulative contributor to low DAO enzyme capacity

The TT genotype is so rare (0.5% in European populations, not observed at all in some smaller study samples) that there is limited published data on its specific phenotypic effect in isolation. The Ayuso 2007 study found negligible independent effect of this variant on serum DAO activity, but that analysis lacked power to detect effects in TT homozygotes given the very low frequency.

In the context of AOC1 research, rs1049742 TT has been observed only in individuals who simultaneously carry other major AOC1 risk variants. Serum DAO activity testing can directly measure your enzyme level and is a useful objective complement to genetic data.